A Case of Euglycemic Diabetic Ketoacidosis With Tirzepatide Use and Severe Calorie Restriction. [PDF]
JCEM Case RepRaptis D +4 more
europepmc +1 more source
Dual GIP/GLP1-RA, GCGR/GLP-1 RA and GLP1-RA for the Treatment of Metabolic Dysfunction-associated Steatotic Liver Disease with Type 2 Diabetes: A Systematic Review and Meta-analysis. [PDF]
touchREV EndocrinolGunawan B, Nugroho H, Sibarani RP.
europepmc +1 more source
GLP-1 and GIP Beyond Glycaemia: Evolutionary Roles in Energy Optimisation and Organ Protection. [PDF]
Diabetes Metab Res RevTuccinardi D +5 more
europepmc +1 more source
Correction to: "Tirzepatide-Induced Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Presenting With Seizures". [PDF]
JCEM Case Repeuropepmc +1 more source
Dual incretin analogue tirzepitide - SURMOUNTing the challenge of obesity induced obstructive sleep apnea. [PDF]
World J Exp MedBajpai J +3 more
europepmc +1 more source
[Side effects and pharmacovigilance of GLP1 agonists]. [PDF]
Aten PrimariaMaria Tablado MA.
europepmc +1 more source
Acute exogenous acyl-GIP treatment enhances lipid handling and fatty acid oxidation by involving brown fat. [PDF]
EMBO RepLyons SA +18 more
europepmc +1 more source
Glucose-Dependent Insulinotropic Polypeptide and Glucagon After Weight Loss Induced by Diet or Bariatric Surgery. [PDF]
Obesity (Silver Spring)Finn A +4 more
europepmc +1 more source
Beyond Diabetes: The Vasculoprotective Effects and Anti-Atherosclerotic Potential of Tirzepatide. [PDF]
Int J Mol SciRzepiński Ł +4 more
europepmc +1 more source